Qube Research & Technologies (QRT)’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,377
Closed -$621K 4570
2024
Q1
$621K Sell
3,377
-380
-10% -$72.4K ﹤0.01% 2415
2023
Q4
$676K Buy
3,757
+3,206
+582% +$499K ﹤0.01% 2131
2023
Q3
$87.6K Sell
551
-3,413
-86% -$558K ﹤0.01% 2698
2023
Q2
$561K Buy
3,964
+2,764
+230% +$443K ﹤0.01% 1486
2023
Q1
$202K Buy
+1,200
New +$214K ﹤0.01% 1936
2022
Q4
Sell
-7,170
Closed -$1.34M 2905
2022
Q3
$1.34M Buy
+7,170
New +$1.51M 0.01% 1086
2022
Q2
Sell
-19,538
Closed -$3.67M 3030
2022
Q1
$3.67M Sell
19,538
-10,670
-35% -$2.03M 0.03% 598
2021
Q4
$8M Buy
30,208
+14,213
+89% +$3.83M 0.06% 406
2021
Q3
$4.62M Sell
15,995
-13,408
-46% -$3.44M 0.06% 435
2021
Q2
$5.87M Buy
+29,403
New +$5.7M 0.07% 354
2021
Q1
Sell
-10,222
Closed -$1.96M 2332
2020
Q4
$1.96M Sell
10,222
-21,294
-68% -$3.87M 0.03% 630
2020
Q3
$4.65M Sell
31,516
-1,619
-5% -$231K 0.07% 376
2020
Q2
$4.1M Buy
+33,135
New +$3.9M 0.06% 419

Other funds holding RGEN

Qube Research & Technologies (QRT)'s RGEN Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of Repligen (RGEN) in Q2 2024, closing a stake of 3,377 shares — an estimated $621K sold.

Qube Research & Technologies (QRT) first reported a position in RGEN in Q2 2020 and held it in 13 quarters. The position peaked at $8M in Q4 2021. 455 funds tracked by Wall St. Rank hold RGEN as of Q2 2024.

  • Qube Research & Technologies (QRT) reported no remaining Repligen position as of Q2 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 3,377 Repligen shares in Q2 2024, an estimated $621K.
  • Qube Research & Technologies (QRT) first reported a position in Repligen in Q2 2020 and held it in 13 quarters.
  • Qube Research & Technologies (QRT)'s Repligen position peaked at $8M in Q4 2021.
  • 455 funds tracked by Wall St. Rank held Repligen as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.